Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur F Kavanaugh

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
The Journal of Rheumatology|December 7, 2005
Macromolecule tumor necrosis factor inhibitors: are more better?Arthur F Kavanaugh
The Journal of Rheumatology. Supplement|May 3, 2006
B cell targeted therapies: safety considerationsArthur F Kavanaugh
Archives of Internal Medicine|January 14, 2004
Evidence-based use of rheumatologic laboratory testsArthur F Kavanaugh
The Journal of Rheumatology|May 26, 2006
Therapies for psoriatic nail disease. A systematic reviewSarah Cassell, Arthur F Kavanaugh
Arthritis and Rheumatism|October 17, 2002
Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody testsArthur F Kavanaugh, Daniel H Solomon,
The Journal of Rheumatology|May 26, 2006
Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelinesArthur F Kavanaugh, Christopher T Ritchlin,
The Journal of Rheumatology|June 3, 2014
GRAPPA treatment recommendations: an update from the GRAPPA 2013 Annual MeetingLaura C Coates, Christopher T Ritchlin, Arthur F Kavanaugh
Rheumatology (Oxford, England)|October 16, 2010
Rheumatology and workAdrian C Jones, Arthur F Kavanaugh, David J Walker
Nature Reviews. Rheumatology|February 20, 2013
The problem of choice: current biologic agents and future prospects in RAErnest H Choy, Arthur F Kavanaugh, Simon A Jones
Rheumatology (Oxford, England)|June 22, 2012
Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugsKarel Pavelka, Arthur F Kavanaugh, Andrea Rubbert-Roth, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Rheumatology|December 7, 2005
Macromolecule tumor necrosis factor inhibitors: are more better?Arthur F Kavanaugh
The Journal of Rheumatology. Supplement|May 3, 2006
B cell targeted therapies: safety considerationsArthur F Kavanaugh
Archives of Internal Medicine|January 14, 2004
Evidence-based use of rheumatologic laboratory testsArthur F Kavanaugh
The Journal of Rheumatology|May 26, 2006
Therapies for psoriatic nail disease. A systematic reviewSarah Cassell, Arthur F Kavanaugh
Arthritis and Rheumatism|October 17, 2002
Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody testsArthur F Kavanaugh, Daniel H Solomon,
The Journal of Rheumatology|May 26, 2006
Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelinesArthur F Kavanaugh, Christopher T Ritchlin,
The Journal of Rheumatology|June 3, 2014
GRAPPA treatment recommendations: an update from the GRAPPA 2013 Annual MeetingLaura C Coates, Christopher T Ritchlin, Arthur F Kavanaugh
Rheumatology (Oxford, England)|October 16, 2010
Rheumatology and workAdrian C Jones, Arthur F Kavanaugh, David J Walker
Nature Reviews. Rheumatology|February 20, 2013
The problem of choice: current biologic agents and future prospects in RAErnest H Choy, Arthur F Kavanaugh, Simon A Jones
Rheumatology (Oxford, England)|June 22, 2012
Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugsKarel Pavelka, Arthur F Kavanaugh, Andrea Rubbert-Roth, et al.
Pageof 4